{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:27:20Z","timestamp":1787506040940,"version":"build-2736575974"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82270865, Henan provincial key research and development projects, No. 231111313200, Henan provincial medical science and technology research program-the provincial and ministerial major projects, No. SBGJ202301002."],"award-info":[{"award-number":["No. 82270865, Henan provincial key research and development projects, No. 231111313200, Henan provincial medical science and technology research program-the provincial and ministerial major projects, No. SBGJ202301002."]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic clinical condition characterized by pathological and physiological interactions among metabolic abnormalities, chronic kidney disease, and cardiovascular diseases, leading to multi-organ dysfunction and a higher incidence of cardiovascular endpoints. Traditional approaches to managing CKM syndrome risk are inadequate in these patients, necessitating strategies targeting specific CKM syndrome risk factors. Increasing evidence suggests that addressing uremic toxins and\/or pathways induced by uremic toxins may reduce CKM syndrome risk and treat the disease. This review explores the interactions among heart, kidney, and metabolic pathways in the context of uremic toxins and underscores the significant role of uremic toxins as potential therapeutic targets in the pathophysiology of these diseases. Strategies aimed at regulating these uremic toxins offer potential avenues for reversing and managing CKM syndrome, providing new insights for its clinical diagnosis and treatment.<\/jats:p>","DOI":"10.3389\/fendo.2025.1500336","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T01:43:53Z","timestamp":1737942233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders"],"prefix":"10.3389","volume":"16","author":[{"given":"Shihan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghua","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Global Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019","volume":"16","author":"Li","year":"2023","journal-title":"Clin Kidney J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.66.S1.3","article-title":"Chronic kidney disease","author":"Ammirati","year":"2020","journal-title":"Rev Da Associacao Med Bras (1992)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet (London England)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: A presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0926","article-title":"Range of risk factor levels, risk control, and temporal trends for nephropathy and end-stage kidney disease in patients with type 1 and type 2 diabetes","volume":"45","author":"Halminen","year":"2022","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13303","article-title":"Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry","volume":"20","author":"Arnold","year":"2018","journal-title":"Diab Obes Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000441578","article-title":"Uremic solutes produced by colon microbes","volume":"40","author":"Tanaka","year":"2015","journal-title":"Blood Purification"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11892-018-1064-7","article-title":"Metabolic abnormalities in diabetes and kidney disease: role of uremic toxins","volume":"18","author":"Koppe","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-011-0291-6","article-title":"Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)","volume":"8","author":"Van Der Kloet","year":"2012","journal-title":"Metabol: Off J Metabol Soc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure","volume":"16","author":"Tang","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9841-8_1","article-title":"Diabetic nephropathy: an overview","volume":"2067","author":"Sagoo","year":"2020","journal-title":"Methods In Mol Biol (Clifton N.J.)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12933-021-01343-1","article-title":"Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease","volume":"20","author":"Sasso","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.02.026","article-title":"Accumulation of protein-bound uremic toxins: the kidney remains the leading culprit in the gut-liver-kidney axis","volume":"97","author":"Jourde-Chiche","year":"2020","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/BF03190428","article-title":"Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate","volume":"27","author":"Banoglu","year":"2002","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"fiy125","DOI":"10.1093\/femsec\/fiy125","article-title":"Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites","volume":"94","author":"Saito","year":"2018","journal-title":"FEMS Microbiol Ecol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.016","article-title":"A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors","volume":"180","author":"Nemet","year":"2020","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.3390\/ijms19103228","article-title":"Trimethylamine N-oxide: A link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function","volume":"19","author":"Canyelles","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1038\/s41598-017-04949-2","article-title":"Key role for the organic anion transporters, OAT1 and OAT3, in the in vivo handling of uremic toxins and solutes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02440314","article-title":"Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.589752","article-title":"The aryl hydrocarbon receptor in chronic kidney disease: friend or foe","volume":"8","author":"Mo","year":"2020","journal-title":"Front In Cell Dev Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12040245","article-title":"Gut-derived metabolites and their role in immune dysfunction in chronic kidney disease","volume":"12","author":"Glorieux","year":"2020","journal-title":"Toxins"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.3390\/ijms22179641","article-title":"The role of the gut microbiome in diabetes and obesity-related kidney disease","volume":"22","author":"Zaky","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00735-24","article-title":"Guild-level signature of gut microbiome for diabetic kidney disease","volume":"15","author":"Tang","year":"2024","journal-title":"MBio"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1159\/000351171","article-title":"Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7150\/thno.45455","article-title":"Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.287","article-title":"p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-\/- mice","volume":"89","author":"Jing","year":"2016","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2007.13.s8-b.9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J Managed Care Pharmacy: JMCP"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1937","article-title":"Indoxyl sulfate-induced activation of (pro)renin receptor is involved in expression of TGF-\u03b21 and \u03b1-smooth muscle actin in proximal tubular cells","volume":"155","author":"Saito","year":"2014","journal-title":"Endocrinology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034026","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"Sun","year":"2012","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/toxins12050300","article-title":"Chronic kidney disease-associated immune dysfunctions: impact of protein-bound uremic retention solutes on immune cells","volume":"12","author":"Espi","year":"2020","journal-title":"Toxins"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01354-w","article-title":"Inflammasome activation in podocytes: a new mechanism of glomerular diseases","volume":"69","author":"Xiong","year":"2020","journal-title":"Inflammation Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221991","article-title":"Macrophage phenotype and its relationship with renal function in human diabetic nephropathy","volume":"14","author":"Zhang","year":"2019","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.kint.2016.10.020","article-title":"The pattern recognition receptor, Mincle, is essential for maintaining the M1 macrophage phenotype in acute renal inflammation","volume":"91","author":"Lv","year":"2017","journal-title":"Kidney Int"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681748","article-title":"Macrophage heterogeneity in kidney injury and fibrosis","volume":"12","author":"Wen","year":"2021","journal-title":"Front In Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106161","article-title":"Pharmacological targeting macrophage phenotype via gut-kidney axis ameliorates renal fibrosis in mice","volume":"178","author":"Xie","year":"2022","journal-title":"Pharmacol Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/toxins12070439","article-title":"Immune dysfunction in uremia 2020","volume":"12","author":"Cohen","year":"2020","journal-title":"Toxins"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000356212","article-title":"Impaired leukocytes autophagy in chronic kidney disease patients","volume":"3","author":"Chen","year":"2013","journal-title":"Cardiorenal Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800787R","article-title":"Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice","volume":"33","author":"Poupeau","year":"2019","journal-title":"FASEB J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2019.00024","article-title":"Dietary and gut microbiota polyamines in obesity- and age-related diseases","volume":"6","author":"Ramos-Molina","year":"2019","journal-title":"Front In Nutr"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.3390\/ijms22136933","article-title":"Dissecting the interplay mechanism between epigenetics and gut microbiota: health maintenance and disease prevention","volume":"22","author":"Wu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2019.03.005","article-title":"Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease","volume":"118","author":"Fan","year":"2019","journal-title":"J Formosan Med Assoc"},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur Heart J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41569-020-0367-y","article-title":"Novel gut microbiota-derived metabolite promotes platelet thrombosis via adrenergic receptor signalling","volume":"17","author":"Huynh","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2019.02.028","article-title":"Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells: A new link between trimethylamine N-oxide and atherosclerotic thrombosis","volume":"177","author":"Cheng","year":"2019","journal-title":"Thromb Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab263","article-title":"Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis","volume":"118","author":"Witkowski","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nature21080","article-title":"Feedback control of AHR signalling regulates intestinal immunity","volume":"542","author":"Schiering","year":"2017","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1038\/s41467-022-34773-w","article-title":"Cryo-EM structure of the agonist-bound Hsp90-XAP2-AHR cytosolic complex","volume":"13","author":"Gruszczyk","year":"2022","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1159\/000299798","article-title":"Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation","volume":"31","author":"Tumur","year":"2010","journal-title":"Am J Nephrol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur Heart J"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013040330","article-title":"Obesity in CKD\u2013what should nephrologists know","volume":"24","author":"Stenvinkel","year":"2013","journal-title":"J Am Soc Nephrol: JASN"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101943","article-title":"Genetically and environmentally predicted obesity in relation to cardiovascular disease: a nationwide cohort study","volume":"58","author":"Ojalehto","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002122","article-title":"Quantifying the underestimation of projected global diabetes prevalence by the International Diabetes Federation (IDF) Diabetes Atlas","volume":"9","author":"T\u00f6nnies","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4031","article-title":"Increased cardiovascular mortality in subjects with metabolic syndrome is largely attributable to diabetes and hypertension in 159,971 Korean adults","volume":"100","author":"Sung","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0253","article-title":"Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers","volume":"59","author":"Furet","year":"2010","journal-title":"Diabetes"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149564","article-title":"Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing","volume":"11","author":"Louis","year":"2016","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12993","article-title":"Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis","volume":"21","author":"Dehghan","year":"2020","journal-title":"Obes Rev"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1359989","article-title":"Multiomics analysis investigating the impact of a high-fat diet in female Sprague-Dawley rats: alterations in plasma, intestinal metabolism, and microbial composition","volume":"11","author":"Zhang","year":"2024","journal-title":"Front In Nutr"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.3390\/nu14235050","article-title":"Ramulus mori (Sangzhi) alkaloids ameliorate obesity-linked adipose tissue metabolism and inflammation in mice","volume":"14","author":"Sun","year":"2022","journal-title":"Nutrients"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1166635","article-title":"Ramulus mori (Sangzhi) alkaloids regulates gut microbiota disorder and its metabolism profiles in obese mice induced by a high-fat diet","volume":"14","author":"Liu","year":"2023","journal-title":"Front In Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2975","article-title":"Characteristics of the gut microbiota and metabolism in patients with latent autoimmune diabetes in adults: A case-control study","volume":"44","author":"Fang","year":"2021","journal-title":"Diabetes Care"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.117.157107","article-title":"Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes","volume":"106","author":"Shan","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/biom13071086","article-title":"Quantitative, targeted analysis of gut microbiota derived metabolites provides novel biomarkers of early diabetic kidney disease in type 2 diabetes mellitus patients","volume":"13","author":"Balint","year":"2023","journal-title":"Biomolecules"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.065517","article-title":"Metabolic communication by SGLT2 inhibition","volume":"149","author":"Billing","year":"2024","journal-title":"Circulation"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.20960\/nh.1642","article-title":"Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre\/probiotics in chronic kidney disease: a systematic review","volume":"35","author":"Lopes","year":"2018","journal-title":"Nutricion Hospital"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2017.11.007","article-title":"Does low-protein diet influence the uremic toxin serum levels from the gut microbiota in nondialysis chronic kidney disease patients","volume":"28","author":"Black","year":"2018","journal-title":"J Renal Nutr"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01183-8","article-title":"Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals","volume":"27","author":"Asnicar","year":"2021","journal-title":"Nat Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"8758","DOI":"10.3390\/ijerph17238758","article-title":"Updating the mediterranean diet pyramid towards sustainability: focus on environmental concerns","volume":"17","author":"Serra-Majem","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0427-3","article-title":"Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses","volume":"33","author":"Galbete","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ejcn.2017.58","article-title":"Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials","volume":"72","author":"Dinu","year":"2018","journal-title":"Eur J Clin Nutr"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2015.1107021","article-title":"A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: Are individual components equal","volume":"57","author":"Grosso","year":"2017","journal-title":"Crit Rev In Food Sci Nutr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12916-024-03455-3","article-title":"Adherence to a Mediterranean diet is associated with a lower risk of diabetic kidney disease among individuals with hyperglycemia: a prospective cohort study","volume":"22","author":"Qu","year":"2024","journal-title":"BMC Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"De Filippis","year":"2016","journal-title":"Gut"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320438","article-title":"Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake","volume":"69","author":"Meslier","year":"2020","journal-title":"Gut"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"De Cabo","year":"2019","journal-title":"New Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","article-title":"Impact of intermittent fasting on health and disease processes","volume":"39","author":"Mattson","year":"2017","journal-title":"Ageing Res Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqaa388","article-title":"Remodeling of the gut microbiome during Ramadan-associated intermittent fasting","volume":"113","author":"Su","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.937771","article-title":"Association between daily eating frequency and mortality in people with diabetes: Findings from NHANES 1999-2014","volume":"10","author":"Xie","year":"2023","journal-title":"Front In Nutr"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2012.07.006","article-title":"Associations of meal frequency and breakfast with obesity and metabolic syndrome traits in adolescents of Northern Finland Birth Cohort 1986","volume":"23","author":"J\u00e4\u00e4skel\u00e4inen","year":"2013","journal-title":"Nutrition Metabol Cardiovasc Dis.: NMCD"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2014.9","article-title":"Eating frequency is inversely associated with blood pressure and hypertension in Korean adults: analysis of the Third Korean National Health and Nutrition Examination Survey","volume":"68","author":"Kim","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000822","article-title":"Eating frequency predicts new onset hypertension and the rate of progression of blood pressure, arterial stiffness, and wave reflections","volume":"34","author":"Karatzi","year":"2016","journal-title":"J Hypertens"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313627","article-title":"The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level","volume":"67","author":"Barton","year":"2018","journal-title":"Gut"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306541","article-title":"Exercise and associated dietary extremes impact on gut microbial diversity","volume":"63","author":"Clarke","year":"2014","journal-title":"Gut"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PloS Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05525-z","article-title":"A microbiome-dependent gut-brain pathway regulates motivation for exercise","volume":"612","author":"Dohnalov\u00e1","year":"2022","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1277921","article-title":"The effects of prebiotic, probiotic or synbiotic supplementation on overweight\/obesity indicators: an umbrella review of the trials' meta-analyses","volume":"15","author":"Rasaei","year":"2024","journal-title":"Front In Endocrinol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1154888","article-title":"Meta-analysis of the effect of probiotics or synbiotics on the risk factors in patients with coronary artery disease","volume":"10","author":"Lei","year":"2023","journal-title":"Front In Cardiovasc Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114514000919","article-title":"Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study","volume":"112","author":"Eslamparast","year":"2014","journal-title":"Br J Nutr"},{"key":"B106","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11745-014-3901-z","article-title":"Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes","volume":"49","author":"Shakeri","year":"2014","journal-title":"Lipids"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuw039","article-title":"Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis","volume":"74","author":"Akbari","year":"2016","journal-title":"Nutr Rev"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.661794","article-title":"Effect of a probiotic combination in an experimental mouse model and clinical patients with chronic kidney disease: A pilot study","volume":"8","author":"Wang","year":"2021","journal-title":"Front In Nutr"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Sci (New York N.Y.)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.11.034","article-title":"Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial","volume":"179","author":"Costanza","year":"2015","journal-title":"Int J Cardiol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.104","article-title":"Probiotic supplements might not be universally-effective and safe: A review","volume":"111","author":"Kothari","year":"2019","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews","volume":"11","author":"Hill","year":"2014","journal-title":"Gastroenterol Hepatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.05.055","article-title":"Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity","volume":"153","author":"Nicolucci","year":"2017","journal-title":"Gastroenterology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Sci (New York N.Y.)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet (London England)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019101029","article-title":"Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A","volume":"31","author":"Li","year":"2020","journal-title":"J Am Soc Nephrol: JASN"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3390\/nu14122528","article-title":"Faecal microbiota transplantation and chronic kidney disease","volume":"14","author":"Bian","year":"2022","journal-title":"Nutrients"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322630","article-title":"Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial","volume":"70","author":"De Groot","year":"2021","journal-title":"Gut"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.06.010","article-title":"Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab"},{"key":"B121","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/toxins12120741","article-title":"Effects of fecal microbiota transplantation on composition in mice with CKD","volume":"12","author":"Barba","year":"2020","journal-title":"Toxins"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j791","article-title":"Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study","volume":"356","author":"Schmidt","year":"2017","journal-title":"BMJ (Clinical Res ed.)"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet (London England)"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02652-5","article-title":"Potential underlying mechanisms explaining the cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors","volume":"41","author":"Verma","year":"2024","journal-title":"Adv In Ther"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"New Engl J Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.861829","article-title":"Antihypertensive therapy by ACEI\/ARB is associated with intestinal flora alterations and metabolomic profiles in hypertensive patients","volume":"10","author":"Dong","year":"2022","journal-title":"Front In Cell Dev Biol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4654-7","article-title":"Development of SGLT1 and SGLT2 inhibitors","volume":"61","author":"Rieg","year":"2018","journal-title":"Diabetologia"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"New Engl J Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac210","article-title":"Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes","volume":"107","author":"Deng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac299","article-title":"Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease","volume":"43","author":"Pandey","year":"2022","journal-title":"Eur Heart J"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057983","article-title":"Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial","volume":"145","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114149","article-title":"Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats","volume":"158","author":"Gonz\u00e1lez-Correa","year":"2023","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611079104","article-title":"Amelioration of progressive renal injury by genetic manipulation of Klotho gene","volume":"104","author":"Haruna","year":"2007","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.445","article-title":"Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation","volume":"81","author":"Sun","year":"2012","journal-title":"Kidney Int"},{"key":"B136","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/toxins10090367","article-title":"Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120","volume":"10","author":"Liu","year":"2018","journal-title":"Toxins"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014060543","article-title":"Klotho protects against indoxyl sulphate-induced myocardial hypertrophy","volume":"26","author":"Yang","year":"2015","journal-title":"J Am Soc Nephrol: JASN"},{"key":"B138","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.toxlet.2012.10.004","article-title":"Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein","volume":"215","author":"Yang","year":"2012","journal-title":"Toxicol Lett"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-744060","article-title":"Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice","volume":"129","author":"Yang","year":"2017","journal-title":"Blood"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and tryptophan metabolism: endogenous and dietary routes to ah receptor activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metab Dispos: Biol Fate Chem"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-043020-090050","article-title":"Diet-host-microbiota interactions shape aryl hydrocarbon receptor ligand production to modulate intestinal homeostasis","volume":"41","author":"Han","year":"2021","journal-title":"Annu Rev Nutr"},{"key":"B142","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry"},{"key":"B143","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.toxlet.2024.04.005","article-title":"Roles of AhR\/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy","volume":"396","author":"Lu","year":"2024","journal-title":"Toxicol Lett"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01061-X","article-title":"Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats","volume":"68","author":"Nihei","year":"2001","journal-title":"Life Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-018-2328-3","article-title":"Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor\/nuclear factor-kappa B signaling pathway in human endothelial cells","volume":"93","author":"Addi","year":"2019","journal-title":"Arch Toxicol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/jcm7100365","article-title":"AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells","volume":"7","author":"Adesso","year":"2018","journal-title":"J Clin Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial","volume":"54","author":"Akizawa","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1773","article-title":"An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys","volume":"15","author":"Miyazaki","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.20731","article-title":"An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats","volume":"37","author":"Aoyama","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1159\/000489772","article-title":"Importance of AST-120 (Kremezin\u00ae) adherence in a chronic kidney disease patient with diabetes","volume":"8","author":"Tomino","year":"2018","journal-title":"Case Rep In Nephrol Dialysis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/srep14381","article-title":"Continuous reduction of protein-bound uraemic toxins with improved oxidative stress by using the oral charcoal adsorbent AST-120 in haemodialysis patients","volume":"5","author":"Yamamoto","year":"2015","journal-title":"Sci Rep"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-015-0785-7","article-title":"Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study","volume":"31","author":"Sato","year":"2016","journal-title":"Heart Vessels"},{"key":"B153","doi-asserted-by":"publisher","first-page":"15571","DOI":"10.1038\/s41598-019-51292-9","article-title":"AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels","volume":"9","author":"Nakada","year":"2019","journal-title":"Sci Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1500336\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T01:43:59Z","timestamp":1737942239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1500336\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":153,"alternative-id":["10.3389\/fendo.2025.1500336"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1500336","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"article-number":"1500336"}}